Ostabolin-C

DB05536InvestigationalSmall molecule

Ostabolin C was under investigation in clinical trial NCT00787358 (A Proof-of-Concept Study Investigating the Safety and Efficacy of ZT-031 on Hip Fracture Healing in Men and Postmenopausal Women (SHIFT)).

Mechanism: Pharmacologically active on Parathyroid hormone/parathyroid hormone-related peptide receptor
Curator reviewed
Primary indication: Investigated for use/treatment in menopause and osteoporosis.Curator reviewed
Also known as: (LEU(SUP 27))CYCLO(GLU(SUP 22)-LYS(SUP 26)-HPTH(1-31)NH2 AMIDE · (LEU27)-CYCLO(GLU22-LYS26)-HPTH-(1-31)-NH2 · L-VALINAMIDE, L-SERYL-L-VALYL-L-SERYL-L-.ALPHA.-GLUTAMYL-L-ISOLEUCYL-L-GLUTAMINYL-L-LEUCYL-L-METHIONYL-L-HISTIDYL-L-ASPARAGINYL-L-LEUCYLGLYCYL-L-LYSYL-L-HISTIDYL-L-LEUCYL-L-ASPARAGINYL-L-SERYL-L-METHIONYL-L-.ALPHA.-GLUTAMYL-L-ARGINYL-L-VALYL-L-.ALPHA.-GL · PTH-1-31 CYCLIC
Code names: ZT-031

Resolves to

Compound

UNIIG492NW2HA7CAS188899-65-2

Targets

Q03431PTH1R

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ostabolin-C, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account